Press releaseBusiness Wire
Cadre Holdings
CDRE · NYSE
$27.05−$0.02 (−0.07%)TodayMarket closed ·
Prev close $27.07
About CDRE
- Employees
- 2,533
- Headquarters
- Jacksonville, Florida
- Listed
- Nov 4, 2021
- Sector
- Industrials
- Industry
- Aerospace & Defense
- Website
- cadre-holdings.com
CDRE key statistics
- Market cap
- 1.16B
- Price-earnings ratio
- 33.42
- Dividend yield
- 1.41%
- Average volume
- 558.27K
- Volume
- 508.19K
- Open price
- $27.22
- High today
- $27.39
- Low today
- $26.09
- 52 Week high
- $48.76
- 52 Week low
- $24.07
Cadre Holdings (CDRE) at a glance
As of Oct 20, 2026, Cadre Holdings (CDRE) shares are priced at $27.05, giving the company a market cap of 1.16B, a price-to-earnings ratio of 33.42 and a dividend yield of 1.41%.
Today the stock has traded between $26.09 and $27.39. The current price is 3.7% above the day's low and 1.2% below its high.
Volume so far is 508.19K shares, in line with the average of 558.27K shares a day.
Over the past year Cadre Holdings has ranged from $24.07 to $48.76, and now sits 12% of the way up that range.
Cadre Holdings met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.26 per share against an estimate of $0.2244.
The average analyst price target is $48.96, 81.0% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
100%of 2 analyst ratings say Buy
- Buy100.0%
- Hold0.0%
- Sell0.0%
Price target · 8 analystsAvg $48.96
- Low
- $43.43
- Now
- $27.05
- High
- $65.10
CDRE earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 32.0% on average.
- Q3 FY24: reported $0.09 per share against an estimate of $0.0629
- Q4 FY24: reported $0.32 per share against an estimate of $0.4692
- Q1 FY25: reported $0.23 per share against an estimate of $0.1224
- Q2 FY25: reported $0.30 per share against an estimate of $0.2696
- Q3 FY25: reported $0.27 per share against an estimate of $0.2652
- Q4 FY25: reported $0.27 per share against an estimate of $0.41
- Q1 FY26: reported $0.05 per share against an estimate of $0.0857
- Q2 FY26: reported $0.26 per share against an estimate of $0.2244
CDRE news
- Piero Cingari
Defense Stocks Enter Bear Market, Hit Longest Losing Streak on Record
- Press releaseBusiness Wire
Cadre Holdings Announces Participation at Upcoming Investor Conferences
- Press releaseBusiness Wire
Cadre Holdings Reports Second Quarter 2026 Financial Results
- Press releaseBusiness Wire
Cadre Holdings Announces Second Quarter 2026 Earnings and Conference Call Information
- Press releaseBusiness Wire
Cadre Holdings Declares Quarterly Dividend of $0.10 Per Share
- Press releaseBusiness Wire
Cadre Holdings Subsidiary Safariland Selected as Ballistic Provider for FBI Armor Contract
Cadre Hldgs Q1 2026 Earnings Call: Complete Transcript
Similar companies
Companies in the same industry as Cadre Holdings
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.